These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15943843)

  • 21. The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial.
    Konturek JW; Beneke M; Koppermann R; Petersen-Braun M; Weingärtner U
    Med Sci Monit; 2007 Jan; 13(1):CR44-9. PubMed ID: 17179910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A placebo-controlled trial of itopride in functional dyspepsia.
    Holtmann G; Talley NJ; Liebregts T; Adam B; Parow C
    N Engl J Med; 2006 Feb; 354(8):832-40. PubMed ID: 16495395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of the placebo response in functional dyspepsia.
    Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL
    Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial.
    Madisch A; Holtmann G; Mayr G; Vinson B; Hotz J
    Digestion; 2004; 69(1):45-52. PubMed ID: 14755152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group.
    Ran ZH; Yuan YZ; Li ZS; Wang JY; Zong CH; Xie WF; Zheng P; Chen SL; Zhan XB; Chen SY; Xiao SD
    J Dig Dis; 2009 Feb; 10(1):41-8. PubMed ID: 19236546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design.
    Madsen LG; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):365-72. PubMed ID: 15274674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial: a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia.
    Hashash JG; Abdul-Baki H; Azar C; Elhajj II; El Zahabi L; Chaar HF; Sharara AI
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1148-55. PubMed ID: 18331614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
    Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study.
    Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE
    Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia.
    Gerson LB; Triadafilopoulos G
    Dig Liver Dis; 2005 Feb; 37(2):87-91. PubMed ID: 15733519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
    Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun AN; Thomson AB; Mann V; Escobedo S; Chakraborty B; Nevin K
    Aliment Pharmacol Ther; 2006 Feb; 23(4):521-9. PubMed ID: 16441473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.